Cardiovascular abnormalities in immune-mediated inflammatory disease

Cardiovascular abnormalities in immune-mediated inflammatory disease

Immune-mediated inflammatory disease (IMID) represents a group of diseases characterised by dysregulation of immune processes with a shared common inflammatory pathway, leading to end-organ damage, of which Rheumatoid Arthritis (RA) and Systemic Sclerosis (SSc) are two important examples. An acceler...

Full description

Bibliographic Details
Main Author:	Bissell, Lesley-Anne
Other Authors:	Buch, Maya ; Andrews, Jacqueline ; Greenwood, John ; Plein, Sven
Published:	University of Leeds 2016
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.702602

Similar Items

Inflammatory and Immune-Mediated Cutaneous Diseases
by: Juarez A. S. Quaresma, et al.
Published: (2017-01-01)

Lysosomal Abnormalities in Cardiovascular Disease
by: Congwu Chi, et al.
Published: (2020-01-01)

Immune-Mediated Cytotoxicity in Inflammatory Bowel Disease
by: Stephan R Targan, et al.
Published: (1990-01-01)

The Gut Microbiota in Immune-Mediated Inflammatory Diseases
by: Jessica D Forbes, et al.
Published: (2016-07-01)

Gut microbiome in immune-mediated inflammatory disease
by: Forbes, Jessica Dawn
Published: (2017)

The importance of immunization in immune-mediated inflammatory disease cannot be overstated
by: Sang Hyoung Park
Published: (2018-07-01)

HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases
by: Fabrizia Bonacina, et al.
Published: (2021-04-01)

Thematic review series: The Immune System and Atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
by: Alan Chait, et al.
Published: (2005-03-01)

Chronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease
by: Alina Podkowińska, et al.
Published: (2020-08-01)

Mycobacterium tuberculosis Immune Response in Patients With Immune-Mediated Inflammatory Disease
by: Elisa Petruccioli, et al.
Published: (2021-08-01)

Tea Polyphenols Regulate Key Mediators on Inflammatory Cardiovascular Diseases
by: Jun-ichi Suzuki, et al.
Published: (2009-01-01)

Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases
by: Yan Jiang, et al.
Published: (2021-03-01)

Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.
by: Takeru Yoshimura, et al.
Published: (2009-12-01)

Heme Cytotoxicity And The Pathogenesis of Immune Mediated Inflammatory Diseases.
by: Rasmus eLarsen, et al.
Published: (2012-05-01)

Inflammatory Bowel Disease: Autoimmune or Immune-mediated Pathogenesis?
by: Zhonghui Wen, et al.
Published: (2004-01-01)

The Potential of OMICs Technologies for the Treatment of Immune-Mediated Inflammatory Diseases
by: Charles Gwellem Anchang, et al.
Published: (2021-07-01)

Main Oral Manifestations in Immune-Mediated and Inflammatory Rheumatic Diseases
by: Roberta Gualtierotti, et al.
Published: (2018-12-01)

IMID-Biobank: Biobank of immune-mediated inflammatory diseases (IMIDs)
by: Julià A, et al.
Published: (2010-11-01)

Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study.
by: Mar Pujades-Rodriguez, et al.
Published: (2020-12-01)

NLRP3 inflammasome, an immune‐inflammatory target in pathogenesis and treatment of cardiovascular diseases
by: Yucheng Wang, et al.
Published: (2020-03-01)

METABOLIC ABNORMALITIES TO ASSESMENT OF RISKS TO CARDIOVASCULAR DISEASES
by: Deise Terezinha Lermen, et al.
Published: (2005-04-01)

Endothelial barrier and its abnormalities in cardiovascular disease
by: Dimitry A Chistiakov, et al.
Published: (2015-12-01)

Immune, Inflammatory, and Oxidative Responses in Cardiovascular Complications
by: Kota V. Ramana, et al.
Published: (2016-01-01)

Inflammatory mediators and lung abnormalities in HIV: A systematic review.
by: Breanne M Head, et al.
Published: (2019-01-01)

The Role of Skin and Orogenital Microbiota in Protective Immunity and Chronic Immune-Mediated Inflammatory Disease
by: Young Joon Park, et al.
Published: (2018-01-01)

Hepatic abnormalities in Inflammatory Bowel disease patients
by: Nuno Vaz Franco de Vieira e Brito
Published: (2019)

Saliva Proteomics as Fluid Signature of Inflammatory and Immune-Mediated Skin Diseases
by: Anna Campanati, et al.
Published: (2021-06-01)

The role of microbiome in the pathogenesis of immune-mediated inflammatory diseases: controversial issues
by: A. M. Lila, et al.
Published: (2021-02-01)

Current approaches to treatment of uveitis in immune-mediated inflammatory rheumatic disease
by: T. A. Lisitsyna, et al.
Published: (2020-09-01)

The Role of Inflammatory Mediators in Immune-to-Brain Communication during Health and Disease
by: Diego Gomez-Nicola, et al.
Published: (2013-01-01)

Bioinformatics methods for the genomics and metabolomics analysis of immune-mediated inflammatory diseases
by: Alonso, Arnald
Published: (2015)

New Frontiers in Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases
Published: (2023)

Inflammatory markers and cardiovascular disease
by: Hammett, Christopher John Keith
Published: (2012)

Abnormalities in Alternative Splicing of Apoptotic Genes and Cardiovascular Diseases
by: Zodwa Dlamini, et al.
Published: (2015-11-01)

The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases.
by: Murray W Enns, et al.
Published: (2018-01-01)

Abnormal Haemodynamic Flow Patterns in Bicuspid Pulmonary Valve Disease
by: Malenka M. Bissell, et al.
Published: (2017-05-01)

Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study
by: Lesuis Nienke, et al.
Published: (2012-08-01)

Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases
by: Na An, et al.
Published: (2019-07-01)

The role of the procalcitonin test in the diagnosis of infections in immune-mediated inflammatory rheumatic diseases
by: N. V. Muravyeva, et al.
Published: (2019-12-01)

Efficacy and safety of tofacitinib for immune-mediated inflammatory rheumatic diseases (Part I)
by: E. L. Nasonov, et al.
Published: (2020-02-01)